Literatur
-
1
Riddell R H, Goldman H, Ransohoff D F. et al .
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.
Hum Pathol.
1983;
14
931-968
-
2
Borchard F, Heilmann K L, Hermanek P. et al .
Definition und klinische Bedeutung der Dysplasie im Verdauungstrakt.
Pathologe.
1991;
12
50-56
-
3 Hermanek P. Malignant polyps - pathological factors governing clinical management. In: Williams GT (ed) Gastrointestinal pathology. Springer, Berlin 1990; p 270 - 293
-
4
Butt J R, Lennard-Jones J E, Ritchie J K.
A practical approach to the risk of cancer in inflammatory bowel disease.
Med Clin N Am.
1980;
64
1203-1220
-
5
Dobbins III W O.
Dysplasia and malignancy in inflammatory bowel disease.
Annu Rev Med.
1984;
35
33-48
-
6
Ransohoff D F.
Colon cancer in ulcerative colitis (editorial).
Gastroenterology.
1988;
94
1089-1091
-
7
Fozard J B, Dixon M F.
Colonoscopic surveillance in ulcerative colitis - dysplasia through the looking glass.
Gut.
1989;
20
285-292
-
8
Desaint B, Legendre C, Florent C.
Dysplasia and cancer in ulcerative colitis.
Hepatogastroenterology.
1989;
36
219-226
-
9
Sacher D B.
Cancer in inflammatory bowel disease.
Curr OP Gastroenterol.
1990;
6
543-546
-
10
Porschen R, Strohmeyer G.
Dysplasie und Karzinomrisiko bei Colitis ulcerosa.
Dtsch Med Wochenschr.
1991;
116
1682-1688
-
11
Bernstein C N, Shanahan F, Weinstein W M.
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?.
Lancet.
1994;
343
71-74
-
12
Ransohoff D F, Riddell R H, Levin B.
Ulcerative colitis and colocnic cancer: problems in assessing the diagnostic usefulness of mucosal dysplasia.
Dis Colon Rectum.
1985;
28
383-388
-
13
Schneider A, Stolte M.
Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis.
Z Gastroenterol.
1993;
31
653-656
-
14
Vieth M, Stolte M, Mueller E, Mueller J, Schneider A.
Bioptical differential diagnosis of adenomas, dysplasias and carcinomas in patients with ulcerative colitis.
Leber Magen Darm.
2000;
30
125-132
-
15
Engelsgjerd M, Farraye F A, Odze R D.
Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.
Gastroenterology.
1999;
117
1288-1294
-
16
Rubin P H, Friedman S, Harpaz N, Goldstein E, Weiser J, Schiller J, Waye J D, Present D H.
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.
Gastroenterology.
1999;
117
1295-1300
-
17
Odze R D, Brown C A, Hartmann C J, Noffsinger A E, Fogt F.
genetic alterations in chronic ulcerative colitis associated adenomas like DALM’s are similar to non colitic sporadic adenomas.
Am J Surg Pathol.
2000;
24
1209-1216
-
18
Fogt F, Poremba C, Shibao K, Itho H, Kohono K. et al .
Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis.
Appl Immunohistochem Molecul Morphol.
2001;
9
143-149
-
19
Mueller E, Vieth M, Stolte M, Mueller J.
The differentiation of true adenomas from colitis- associated dysplasia in ulcerative colitis: a comparative immunohistochemical study.
Hum Pathol.
1999;
30
898-905
-
20
Walsh S V, Loda M, Torres C M, Antonioli D, Odze R D.
P53 and beta catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study.
Am Surg Pathol.
1999;
23
963-969
-
21
Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio L B. et al .
Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.
Cancer Res.
1995;
55
2035-2038
-
22
Fogt F, Vortmeyer A O, Goldman H, Giordano T J, Merino M J, Zhuang Z.
Comparison of genetic alterations in colonic adenoma and ulcerative colitis- associated dysplasia and carcinoma.
Hum Pathol.
1998;
29
131-136
-
23
Fogt F, Urbanski S J, Sanders M E, Furth E E, Zimmerman R L, Deren J J. et al .
Distinction between dysplasia associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis.
Hum Pathol.
2000;
31
288-291
-
24
Fogt F, Vortmeyer A O, Stolte M, Mueller E, Mueller J. et al .
Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplastic in ulcerative colitis or sporadic adenomas.
Hum Pathol.
1998;
29
961-964
-
25 Jass J R, Sobin L H. Histological typing of intestinal tumours. 2nd ed. Springer, Berlin 1989
-
26
Schneider A, Stolte M.
Colitis ulcerosa: Differentialdiagnose zwischen Dysplasie und Adenom.
Verh Dtsch Ges Path.
1991;
75
389
-
27
Wolff W I, Shinya H.
definitve treatment of “malignant” polyp of the colon.
Ann Surg.
1975;
182
516-524
-
28
Hermanek P.
Polypectomy in the colorectum: histological and oncological aspects.
Endoscopy.
1983;
15
158-161
-
29
Nugent F E, Haggitt R C, Colcher H, Kutteruf G C.
Malignant potential of chronic ulcerative colitis. Preliminary report.
Gastroenterology.
1979;
76
1-5
-
30
Schneider A, Stolte M.
Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis.
Z’Gastroenterol.
1993;
31
192-197
-
31
Vieth M, Behrens H, Stolte M.
Sporadic adenoma and colitis-associated intraepithelial neoplasia: a difficult differential diagnosis.
Pathologe.
2003;
24
36-43
-
32
Kiesslich R, Fritsch J, Holtmann M, Koehler H H, Stolte M, Kanzler S, Nafe B, Jung M, Galle P R, Neurath M F.
Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.
Gastroenterology.
2003;
124
880-888
Dr. med. M. Vieth
Institut für Pathologie · Otto-von-Guericke Universität
Leipziger Str. 44
39120 Magdeburg
Phone: 03 91/6 71 58 17
